About the Authors

Rakesh K Jain

To whom correspondence should be addressed. E-mail: Jain@steele.mgh.harvard.edu

Johanna Lahdenranta
Dai Fukumura

Competing Interests

RKJ is a grantee of AstraZeneca and a consultant to AstraZeneca, Dyax, and Pfizer. He has received an honorarium from Roche. JL and DF declare that they have no competing interests.